Amgen & Horizon Therapeutics in the spotlight
FTC Pauses Biotech Rally, But Show Must Go On...
The biotech rally has been put on pause on news of the FTC lawsuit to block Amgen’s ($AMGN) acquisition of Horizon Therapeutics ($HZNP). Investors are now worried about other big M&A deals that have been announced so far in 2023. What are the implications of this move by the FTC, if any?
Level Playing Field for Smaller Bios by Slowing Big-Ticket M&A? - U…